| || |
Arthur Bradwell, MD
University of Birmingham
Birmingham, We United Kingdom
Arthur Bradwell, is Honorary Professor of Clinical Immunology in the Division of Immunity & Infection, The Medical School, University of Birmingham. He is also Chairman of The Binding Site Ltd., a University “spin-off” company who manufacture the free light chain assay. His research concerns serum free light chain measurements in patients with multiple myeloma, AL amyloidosis, MGUS, and other monoclonal gammopathies. He is currently involved with clinical trials with patients who have multiple myeloma are in renal failure.
In addition he is studying immunotherapy in patients with parathyroid carcinoma.